E Moreno-Viguri, S Pérez-Silanes - Rev. Virtual Quím, 2013 - academia.edu
More than 100 million people are at risk of contracting Chagas disease. It is estimated that in 2008, Chagas disease was responsible for the death of more than 10,000 people. Despite …
J Soto‐Sánchez, JD Ospina‐Villa - Chemical Biology & Drug …, 2021 - Wiley Online Library
Parasitic diseases are a public health problem, especially in developing countries where millions of people are affected every year. Current treatments have several drawbacks …
E Vicente, B Solano, A Burguete, S Ancizu… - 2007 - dadun.unav.edu
Las enfermedades olvidadas son un grupo de enfermedades infecciosas médicamente diversas entre las que se encuentran tuberculosis, malaria, leishmaniasis y la enfermedad …
E Torres, E Moreno-Viguri, S Galiano… - European journal of …, 2013 - Elsevier
As a continuation of our research and with the aim of obtaining new agents against Chagas disease, an extremely neglected disease which threatens 100 million people, eighteen new …
M Santivañez-Veliz, E Moreno-Viguri… - Revista de la …, 2013 - scielo.org.pe
La tuberculosis requiere nuevos tratamientos frente a su compleja resistencia como MDR- TB y XDR-TB. Las quinoxalinas presentan una amplia variedad de propiedades biológicas …
S Pérez-Silanes, E Torres, L Arbillaga, J Varela… - Bioorganic & medicinal …, 2016 - Elsevier
We report the synthesis and in vitro activity against Trypanosoma cruzi epimastigotes of 15 novel quinoxaline derivatives. Ten of the derivatives presented IC 50 values lower than the …
In search of alternatives to antimicrobial agents currently in use, and in order to respond to the landscape of loss of efficacy due to the emergence of resistance, several research …